Prosecution Insights
Prosecution Insights
7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (57%) |
| §112 only | 1 (14%) |
| No statute on record | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUTTER, GILLIAN A | 1 | 54.9% | +46.1% |
| WESTERBERG, NISSA M | 1 | 23.4% | +36.9% |
| NGANGA, BONIFACE N | 1 | 64.1% | +30.1% |
| MOORE, SUSANNA | 1 | 68.1% | +31.8% |
| MULLINS, JESSICA LYNN | 1 | 49.0% | +32.7% |
| SOROUSH, LAYLA | 1 | 40.2% | +43.6% |
| ISMAIL, REHANA | 1 | 78.9% | +30.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19273752 | ORAL FORMULATIONS OF DEURUXOLITINIB | WESTERBERG, NISSA M | 40d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19030287 | ADJUSTABLE ILLUMINATORS AND METHODS FOR PHOTODYNAMIC THERAPY AND DIAGNOSIS | NGANGA, BONIFACE N | 74d overdue |
| 17854066 | PHOTODYNAMIC THERAPY METHOD FOR SKIN DISORDERS | SOROUSH, LAYLA | 56d overdue |
| 17981237 | PHOTODYNAMIC THERAPY ILLUMINATOR DEVICES AND METHODS | MULLINS, JESSICA LYNN | 51d overdue |
| 18078571 | DEUTERATED DERIVATIVES OF RUXOLITINIB | MOORE, SUSANNA | 31d overdue |
| 19294542 | METHODS OF TREATMENT OF JAK INHIBITION RESPONSIVE CONDITIONS WITH DEUTERATED JAK INHIBITORS | HUTTER, GILLIAN A | 9d overdue |
| 17614323 | DEUTERATED ANALOGS OF D-SERINE AND USES THEREOF | ISMAIL, REHANA | 4d overdue |
| 19273752 | ORAL FORMULATIONS OF DEURUXOLITINIB | WESTERBERG, NISSA M | 40d |
| Art Unit | Apps |
|---|---|
| 1625 | 2 |
| 1618 | 1 |
| 3797 | 1 |
| 1624 | 1 |
| 3792 | 1 |
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19294542 | METHODS OF TREATMENT OF JAK INHIBITION RESPONSIVE CONDITIONS WITH DEUTERATED JAK INHIBITORS | HUTTER, GILLIAN A | 1625 | Other | Non-Final OA | 9d overdue | Pending | Aug 08, 2025 |
| 19273752 | ORAL FORMULATIONS OF DEURUXOLITINIB | WESTERBERG, NISSA M | 1618 | Other | Final Rejection | 40d | Pending | Jul 18, 2025 |
| 19030287 | ADJUSTABLE ILLUMINATORS AND METHODS FOR PHOTODYNAMIC THERAPY AND DIAGNOSIS | NGANGA, BONIFACE N | 3797 | §103 | Non-Final OA | 74d overdue | Pending | Jan 17, 2025 |
| 18078571 | DEUTERATED DERIVATIVES OF RUXOLITINIB | MOORE, SUSANNA | 1624 | §103 | Non-Final OA | 31d overdue | Pending | Dec 09, 2022 |
| 17981237 | PHOTODYNAMIC THERAPY ILLUMINATOR DEVICES AND METHODS | MULLINS, JESSICA LYNN | 3792 | §103 | Non-Final OA | 51d overdue | Pending | Nov 04, 2022 |
| 17854066 | PHOTODYNAMIC THERAPY METHOD FOR SKIN DISORDERS | SOROUSH, LAYLA | 1622 | §103 | Final Rejection | 56d overdue | Pending | Jun 30, 2022 |
| 17614323 | DEUTERATED ANALOGS OF D-SERINE AND USES THEREOF | ISMAIL, REHANA | 1625 | §112 | Non-Final OA | 4d overdue | Pending | Nov 24, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial